Clinical trial
Zidovudine / Lamivudine + Nevirapine Twice Daily, Versus Tenofovir + Lamivudine…
NCT00199979 · MEDEX, Other · Unknown status
Key facts
| NCT number | NCT00199979 |
|---|---|
| Title | Zidovudine / Lamivudine + Nevirapine Twice Daily, Versus Tenofovir + Lamivudine + Nevirapine Once Daily in ARV-Naive Patients |
| Official title | Multicenter, Randomized, Open-Label Trial, Assessing the Efficacy of Zidovudine, Lamivudine and Nevirapine Combination Administered Twice Daily, Versus the Association of Tenofovir, Lamivudine and Nevirapine, Once Daily, in Antiretroviral Naive HIV-1 Infected Patients |
| Lead sponsor | MEDEX, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hiv Infection With Antiretroviral Therapy Indication, CD4 Below 350/µL or Below 15% |
| Intervention type | Drug |
| Interventions | Nevirapine |
| Enrollment | 250 |
| Start date | Apr 1, 2005 |
| Completion | Jun 1, 2008 |
| First posted | Sep 20, 2005 |
| Last update posted | Dec 16, 2005 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: